RDUS
Radius Health Inc
Price:  
23.97 
USD
Volume:  
145,991.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RDUS EV/EBITDA

193.9%
Upside

As of 2024-02-26, the EV/EBITDA ratio of Radius Health Inc (RDUS) is 8.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RDUS's latest enterprise value is 947.32 mil USD. RDUS's TTM EBITDA according to its financial statements is 115.08 mil USD. Dividing these 2 quantities gives us the above RDUS EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 13.1x - 14.7x 14.2x
Forward P/E multiples 17.3x - 20.6x 17.9x
Fair Price 44.16 - 107.71 70.45
Upside 84.2% - 349.3% 193.9%
23.97 USD
Stock Price
70.45 USD
Fair Price

RDUS EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-02-23 -25.82
2024-02-22 -25.51
2024-02-21 -25.63
2024-02-20 -26.02
2024-02-16 -26.96
2024-02-15 -26.96
2024-02-14 -26.02
2024-02-13 -25.24
2024-02-12 -27.38
2024-02-09 -26.78
2024-02-08 -26.46
2024-02-07 -26.33
2024-02-06 -26.40
2024-02-05 -26.47
2024-02-02 -27.25
2024-02-01 -28.11
2024-01-31 -28.36
2024-01-30 -29.37
2024-01-29 -29.17
2024-01-26 -27.94
2024-01-25 -28.38
2024-01-24 -27.81
2024-01-23 -27.76
2024-01-22 -27.78
2024-01-19 -27.45
2024-01-18 -28.19
2024-01-17 -27.98
2024-01-16 -28.27
2024-01-12 -29.20
2024-01-11 -29.15
2024-01-10 -29.45
2024-01-09 -29.37
2024-01-08 -30.32
2024-01-05 -29.99
2024-01-04 -29.33
2024-01-03 -31.78
2024-01-02 -32.71
2023-12-29 -32.49
2023-12-28 -33.97
2023-12-27 -34.05
2023-12-26 -33.89
2023-12-22 -33.67
2023-12-21 -33.38
2023-12-20 -32.88
2023-12-19 -32.75
2023-12-18 -31.37
2023-12-15 -31.81
2023-12-14 -31.81
2023-12-13 -29.46
2023-12-12 -28.38